New York, United States, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Onychomycosis is a fungal condition that affects the fingernails and toenails and can be painful, ugly, and persistent. Several types of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. No prescription was prescribed in 82% of the dermatology ...

In 2022, North America dominated the market with the highest revenue share of 43.0%. Europe will grow at a CAGR of 5.0% from 2023-2032. Asia-Pacific held a 22.5% revenue share in 2022. According to ...

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...

Please provide your email address to receive an email when new articles are posted on . Treatment efficacy was achieved by 76.67% of the continuous regimen group vs. 26.67% of the pulsed group (P = ...

Awareness programs by non-profit organizations about onychomycosis treatment have increased the awareness level among people about onychomycosis treatment in developed economies, which is consequently ...

Subungual onychomycosis is the most common type of toenail fungus and affects the nail bed and underside of the nail. White superficial onychomycosis causes white spots and flaky patches on the ...

Prior to initiating treatment with antifungal therapy for onychomycosis, it is important that a differential diagnosis is made to eliminate other possible conditions. This is because there are certain ...

Accounting for approximately 12% of the entire fungal infection treatments space, onychomycosis treatment has been witnessing a high prevalence-low awareness scenario over the years. However, ...

Onychomycosis is the most common cause of chronic nail thickening and discoloration, affecting up to 14% of adults in North America. [1,2] Antifungal treatments range in efficacy, with systemic drugs ...